KaloBios announces Martin Shkreli's sale of his stake in the company
KaloBios Pharmaceuticals announced the sale by Martin Shkreli of his remaining shares of KaloBios common stock, fully eliminating his association with the company. KaloBios also outlined its priority goals as it continues to transform the company. August 29, 2016